CDT
CDT Equity Inc.
Price Chart
Latest Quote
$1.02
+0.33 (+47.19%)
Current Price
| Previous Close | $0.69 |
| Open | $1.35 |
| Day High | $1.80 |
| Day Low | $0.87 |
| Volume | 245,049,080 |
Stock Information
| Shares Outstanding | 4.86M |
| Total Debt | $775K |
| Cash Equivalents | $1.51M |
| Net Income | $-39.22M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $4.96M |
| EPS (TTM) | $-1177.89 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $2.75M |
| Income | $-39.22M |
| Book/sh | $-77.82 |
| Cash/sh | $0.31 |
| Employees | 4 |
Financial Ratios
| Quick Ratio | 0.12 |
| Current Ratio | 0.34 |
Returns & Margins
| ROA | -344.95% |
Ownership
| Insider Ownership | 77.66% |
| Institutional Ownership | 0.00% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/B | -0.01 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.86 |
| SMA50 | $1.99 |
| SMA200 | $44.61 |
| RSI | 48.87 |
| ATR | 0.1635 |
| Shares Float | 2.26M |
| Short Float | 2.10% |
| Short Ratio | 0.02 |
| Volatility | 1.41 |
| Rel Volume | 16.48 |
Performance History
| Week | +42.06% |
| Month | -15.00% |
| Quarter | -91.54% |
| 6 Months | -97.61% |
| YTD | -97.17% |
| Year | -99.78% |
| 3 Years | -100.00% |
| 10 Years | -100.00% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $1.02 | 248,337,800 |
| 2026-06-17 | $0.69 | 44,100 |
| 2026-06-16 | $0.72 | 71,800 |
| 2026-06-15 | $0.71 | 83,200 |
| 2026-06-12 | $0.70 | 152,700 |
| 2026-06-11 | $0.72 | 158,700 |
| 2026-06-10 | $0.72 | 114,900 |
| 2026-06-09 | $0.74 | 207,200 |
| 2026-06-08 | $0.77 | 301,600 |
| 2026-06-05 | $0.74 | 322,200 |
| 2026-06-04 | $0.85 | 405,400 |
| 2026-06-03 | $0.81 | 309,600 |
| 2026-06-02 | $0.85 | 473,300 |
| 2026-06-01 | $0.89 | 1,612,500 |
| 2026-05-29 | $1.04 | 46,121,100 |
| 2026-05-28 | $0.95 | 266,000 |
| 2026-05-27 | $1.10 | 1,464,000 |
| 2026-05-26 | $0.88 | 300,400 |
| 2026-05-22 | $1.05 | 336,700 |
| 2026-05-21 | $1.22 | 325,500 |
| 2026-05-20 | $1.23 | 271,000 |
| 2026-05-19 | $1.20 | 1,266,300 |
About CDT Equity Inc.
CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets. The company's pipeline includes AZD1656, a glucokinase activator that is in Phase II trials for the treatment of autoimmune disorders, including uveitis, Hashimoto's thyroiditis, preterm labor, and renal transplant; AZD5658, which is in Phase I clinical trial for the treatment of Type 2 Diabetes Mellitus; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It also provides treatments for inflammatory disorders, oncology, dermatology, rare diseases and animal health. The company was formerly known as Conduit Pharmaceuticals Inc. and changed its name to CDT Equity Inc. in August 2025. The company was founded in 2019 and is based in Naples, Florida.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 | $0 |
| Expenses | ||||
| Interest Expense | $319,000 | $1,506,000 | $211,000 | $0 |
| Total Expenses | $36,660,000 | $15,105,000 | $5,262,000 | $3,160,000 |
| Other Income Expense | $-2,273,000 | $-1,204,000 | $8,300,000 | $-1,727,000 |
| Other Non Operating Income Expenses | $-2,673,000 | $-705,000 | $1,400,000 | $-265,000 |
| Net Non Operating Interest Income Expense | $-291,000 | $-1,493,000 | $-196,000 | $0 |
| Interest Expense Non Operating | $319,000 | $1,506,000 | $211,000 | $0 |
| Operating Expense | $36,660,000 | $15,105,000 | $5,262,000 | $3,160,000 |
| General And Administrative Expense | $31,703,000 | $12,041,000 | $5,172,000 | $3,049,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-39,224,000 | $-17,802,000 | $-535,000 | $-4,887,000 |
| Net Interest Income | $-291,000 | $-1,493,000 | $-196,000 | $0 |
| Interest Income | $28,000 | $13,000 | $15,000 | $0 |
| Normalized Income | $-39,624,000 | $-17,303,000 | $-5,986,000 | $-3,425,000 |
| Net Income From Continuing And Discontinued Operation | $-39,224,000 | $-17,802,000 | $-535,000 | $-4,887,000 |
| Total Operating Income As Reported | $-36,757,000 | $-15,419,000 | $-5,262,000 | $-3,160,000 |
| Net Income Common Stockholders | $-39,224,000 | $-17,802,000 | $-535,000 | $-4,887,000 |
| Net Income | $-39,224,000 | $-17,802,000 | $-535,000 | $-4,887,000 |
| Net Income Including Noncontrolling Interests | $-39,224,000 | $-17,802,000 | $2,842,000 | $-4,887,000 |
| Net Income Continuous Operations | $-39,224,000 | $-17,802,000 | $2,842,000 | $-4,887,000 |
| Pretax Income | $-39,224,000 | $-17,802,000 | $2,842,000 | $-4,887,000 |
| Special Income Charges | $246,000 | $-706,000 | - | - |
| Interest Income Non Operating | $28,000 | $13,000 | $15,000 | $0 |
| Operating Income | $-36,660,000 | $-15,105,000 | $-5,262,000 | $-3,160,000 |
| Average Dilution Earnings | - | $0 | $-5,521,000 | - |
| Per Share | ||||
| Diluted EPS | $-1177.89 | $-38616.05 | $-24617.89 | $-20278.01 |
| Basic EPS | $-1177.89 | $-38616.05 | $-2174.80 | $-20278.01 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $1,449,000 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-36,880,000 | $-15,340,000 | $-3,847,000 | $-3,425,000 |
| Total Unusual Items | $400,000 | $-499,000 | $6,900,000 | $-1,462,000 |
| Total Unusual Items Excluding Goodwill | $400,000 | $-499,000 | $6,900,000 | $-1,462,000 |
| Reconciled Depreciation | $2,425,000 | $457,000 | $0 | - |
| EBITDA (Bullshit earnings) | $-36,480,000 | $-15,839,000 | $3,053,000 | $-4,887,000 |
| EBIT | $-38,905,000 | $-16,296,000 | $3,053,000 | $-4,887,000 |
| Diluted Average Shares | $33,300 | $461 | $246 | $241 |
| Basic Average Shares | $33,300 | $461 | $246 | $241 |
| Diluted NI Availto Com Stockholders | $-39,224,000 | $-17,802,000 | $-6,056,000 | $-4,887,000 |
| Gain On Sale Of Ppe | $-403,000 | $0 | - | - |
| Other Special Charges | $-649,000 | $706,000 | - | - |
| Gain On Sale Of Security | $154,000 | $207,000 | $6,900,000 | $-1,462,000 |
| Other Taxes | $-97,000 | $-314,000 | - | - |
| Research And Development | $5,054,000 | $3,378,000 | $90,000 | $111,000 |
| Selling General And Administration | $31,703,000 | $12,041,000 | $5,172,000 | $3,049,000 |
| Other Gand A | $31,703,000 | $12,041,000 | $5,172,000 | $3,049,000 |
Fetched: 2026-06-11
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-7,170,000 | $-6,793,000 | $-457,000 | $-10,094,000 |
| Total Assets | $5,650,000 | $4,193,000 | $7,224,000 | $5,000 |
| Total Non Current Assets | $1,271,000 | $1,478,000 | $1,491,000 | $5,000 |
| Other Non Current Assets | $860,000 | $1,175,000 | $1,491,000 | - |
| Current Assets | $4,379,000 | $2,715,000 | $5,733,000 | $0 |
| Other Current Assets | $1,823,000 | $1,781,000 | - | - |
| Prepaid Assets | $1,047,000 | $380,000 | $1,505,000 | $0 |
| Cash Cash Equivalents And Short Term Investments | $1,509,000 | $554,000 | $4,228,000 | $0 |
| Cash And Cash Equivalents | $1,509,000 | $554,000 | $4,228,000 | $0 |
| Receivables | - | $489,000 | $0 | - |
| Other Receivables | - | $489,000 | - | - |
| Goodwill And Other Intangible Assets | - | - | $0 | $5,000 |
| Other Intangible Assets | - | - | - | $5,000 |
| Debt | ||||
| Total Debt | $775,000 | $7,457,000 | $985,000 | $2,010,000 |
| Long Term Debt And Capital Lease Obligation | $0 | $107,000 | $0 | $1,835,000 |
| Current Debt And Capital Lease Obligation | $775,000 | $7,350,000 | $985,000 | $175,000 |
| Current Debt | $660,000 | $7,231,000 | $985,000 | $175,000 |
| Other Current Borrowings | $660,000 | $6,656,000 | $800,000 | $175,000 |
| Net Debt | - | $6,677,000 | - | $2,010,000 |
| Long Term Debt | - | - | - | $1,835,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $12,820,000 | $10,986,000 | $7,681,000 | $10,094,000 |
| Total Non Current Liabilities Net Minority Interest | $0 | $245,000 | $5,880,000 | $5,918,000 |
| Derivative Product Liabilities | $0 | $138,000 | $142,000 | $0 |
| Current Liabilities | $12,820,000 | $10,741,000 | $1,801,000 | $4,176,000 |
| Current Notes Payable | $0 | $575,000 | $185,000 | - |
| Payables And Accrued Expenses | $12,045,000 | $3,391,000 | $816,000 | $2,584,000 |
| Payables | $1,913,000 | $1,428,000 | $215,000 | - |
| Accounts Payable | $1,913,000 | $1,428,000 | $215,000 | $0 |
| Tradeand Other Payables Non Current | - | $0 | $5,738,000 | $0 |
| Non Current Deferred Liabilities | - | - | $0 | $4,083,000 |
| Other Current Liabilities | - | - | - | $1,417,000 |
| Equity | ||||
| Common Stock Equity | $-7,170,000 | $-6,793,000 | $-457,000 | $-10,089,000 |
| Total Equity Gross Minority Interest | $-7,170,000 | $-6,793,000 | $-457,000 | $-10,089,000 |
| Stockholders Equity | $-7,170,000 | $-6,793,000 | $-457,000 | $-10,089,000 |
| Gains Losses Not Affecting Retained Earnings | $-16,000 | $414,000 | $411,000 | $675,000 |
| Other Equity Adjustments | $-16,000 | $414,000 | $411,000 | $675,000 |
| Retained Earnings | $-68,325,000 | $-29,101,000 | $-11,299,000 | $-10,770,000 |
| Other | ||||
| Ordinary Shares Number | $92,140 | $461 | $246 | $241 |
| Share Issued | $92,140 | $461 | $246 | $241 |
| Tangible Book Value | $-7,170,000 | $-6,793,000 | $-457,000 | $-10,094,000 |
| Invested Capital | $-6,510,000 | $438,000 | $528,000 | $-8,079,000 |
| Working Capital | $-8,441,000 | $-8,026,000 | $3,932,000 | $-4,176,000 |
| Capital Lease Obligations | $115,000 | $226,000 | $0 | - |
| Total Capitalization | $-7,170,000 | $-6,793,000 | $-457,000 | $-8,254,000 |
| Additional Paid In Capital | $61,171,000 | $21,894,000 | $10,424,000 | $0 |
| Capital Stock | $0 | $0 | $7,000 | $6,000 |
| Common Stock | $0 | $0 | $7,000 | $6,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $0 | $107,000 | $0 | - |
| Current Capital Lease Obligation | $115,000 | $119,000 | $0 | - |
| Current Accrued Expenses | $10,132,000 | $1,963,000 | $601,000 | $2,584,000 |
| Net PPE | $411,000 | $303,000 | $0 | - |
| Gross PPE | $411,000 | $303,000 | $0 | - |
| Other Properties | $411,000 | $303,000 | - | - |
| Non Current Deferred Revenue | - | - | $0 | $4,083,000 |
Fetched: 2026-06-11
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-17,958,000 | $-9,733,000 | $-7,725,000 | $-2,266,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-15,555,000 | $-9,682,000 | $-7,725,000 | $-2,266,000 |
| Cash Flow From Continuing Operating Activities | $-15,555,000 | $-9,682,000 | $-7,725,000 | $-2,266,000 |
| Operating Gains Losses | $-29,000 | $3,201,000 | $-5,625,000 | $1,429,000 |
| Investing Activities | ||||
| Capital Expenditure | $-2,403,000 | $-51,000 | - | - |
| Investing Cash Flow | $-808,000 | $-43,000 | $725,000 | $-183,000 |
| Cash Flow From Continuing Investing Activities | $-808,000 | $-43,000 | $725,000 | $-183,000 |
| Net Other Investing Changes | - | - | $228,000 | $-331,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-106,000 | $0 | - | - |
| Issuance Of Capital Stock | $19,699,000 | $3,328,000 | $0 | $1,341,000 |
| Financing Cash Flow | $17,422,000 | $6,067,000 | $10,929,000 | $2,448,000 |
| Cash Flow From Continuing Financing Activities | $17,422,000 | $6,067,000 | $10,929,000 | $2,448,000 |
| Net Common Stock Issuance | $19,593,000 | $3,328,000 | $0 | $1,341,000 |
| Common Stock Issuance | $19,699,000 | $3,328,000 | $0 | $1,341,000 |
| Net Other Financing Charges | - | - | $8,643,000 | - |
| Other | ||||
| Repayment Of Debt | $-2,171,000 | $-776,000 | $0 | - |
| Issuance Of Debt | $0 | $3,226,000 | $2,286,000 | $1,107,000 |
| Interest Paid Supplemental Data | $0 | $80,000 | $124,000 | $0 |
| End Cash Position | $1,509,000 | $554,000 | $4,228,000 | $0 |
| Beginning Cash Position | $554,000 | $4,228,000 | $0 | $0 |
| Effect Of Exchange Rate Changes | $-104,000 | $-16,000 | $299,000 | $1,000 |
| Changes In Cash | $1,059,000 | $-3,658,000 | $3,929,000 | $-1,000 |
| Proceeds From Stock Option Exercised | $0 | $289,000 | $0 | - |
| Common Stock Payments | $-106,000 | $0 | - | - |
| Net Issuance Payments Of Debt | $-2,171,000 | $2,450,000 | $2,286,000 | $1,107,000 |
| Net Short Term Debt Issuance | $-2,171,000 | $2,450,000 | $2,286,000 | - |
| Short Term Debt Payments | $-2,171,000 | $-776,000 | $0 | - |
| Short Term Debt Issuance | $0 | $3,226,000 | $2,286,000 | - |
| Net Investment Purchase And Sale | $0 | $8,000 | $497,000 | $148,000 |
| Sale Of Investment | $0 | $498,000 | $497,000 | $148,000 |
| Purchase Of Investment | $0 | $-490,000 | $0 | - |
| Net Intangibles Purchase And Sale | $-403,000 | $0 | - | - |
| Sale Of Intangibles | $1,595,000 | $0 | - | - |
| Purchase Of Intangibles | $-1,998,000 | $0 | - | - |
| Net PPE Purchase And Sale | $-405,000 | $-51,000 | $0 | - |
| Purchase Of PPE | $-405,000 | $-51,000 | $0 | - |
| Change In Working Capital | $4,727,000 | $-142,000 | $-2,516,000 | $596,000 |
| Change In Other Current Liabilities | $9,469,000 | $-124,000 | $0 | - |
| Change In Payables And Accrued Expense | $-680,000 | $2,255,000 | $-1,531,000 | $601,000 |
| Change In Accrued Expense | $-1,114,000 | $1,030,000 | $-1,746,000 | $601,000 |
| Change In Payable | $434,000 | $1,225,000 | $215,000 | - |
| Change In Account Payable | $434,000 | $1,225,000 | $215,000 | $0 |
| Change In Prepaid Assets | $-4,062,000 | $-2,273,000 | $-990,000 | $0 |
| Other Non Cash Items | $14,363,000 | $2,972,000 | $992,000 | $265,000 |
| Stock Based Compensation | $2,183,000 | $1,632,000 | $199,000 | $0 |
| Depreciation Amortization Depletion | $2,425,000 | $457,000 | $0 | - |
| Depreciation And Amortization | $2,425,000 | $457,000 | $0 | - |
| Amortization Cash Flow | $2,404,000 | $447,000 | $0 | - |
| Amortization Of Intangibles | $2,404,000 | $447,000 | $0 | - |
| Depreciation | $21,000 | $10,000 | $0 | - |
| Gain Loss On Investment Securities | $265,000 | $2,481,000 | $-5,598,000 | $1,429,000 |
| Net Foreign Currency Exchange Gain Loss | $-16,000 | $13,000 | $-39,000 | $0 |
| Net Income From Continuing Operations | $-39,224,000 | $-17,802,000 | $-535,000 | $-4,887,000 |
| Change In Other Current Assets | - | $0 | $5,000 | $-5,000 |
| Provisionand Write Offof Assets | - | $0 | $-240,000 | $331,000 |
| Net Long Term Debt Issuance | - | - | $2,286,000 | $1,107,000 |
| Long Term Debt Issuance | - | - | $2,286,000 | $1,107,000 |
| Change In Other Working Capital | - | - | - | $331,000 |
Fetched: 2026-06-11